Loading clinical trials...
Loading clinical trials...
A Double-blind, Randomized Clinical Trial Evaluating the Efficacy and Safety of Vormatrigine in Adults With Focal Seizures
Conditions
Interventions
40 mg/day vormatrogine for 12 weeks
30 mg/day vormatrogine for 12 weeks
+2 more
Locations
7
United States
Praxis Research Site
Miami, Florida, United States
Praxis Research Site
Miami Lakes, Florida, United States
Praxis Research Site
Naples, Florida, United States
Praxis Research Site
Marlboro, New Jersey, United States
Praxis Research Site
Niagara Falls, New York, United States
Praxis Research Site
Raleigh, North Carolina, United States
Start Date
January 29, 2026
Primary Completion Date
January 1, 2027
Completion Date
May 1, 2027
Last Updated
April 1, 2026
NCT07219407
NCT07238868
NCT06716801
NCT04653012
NCT05981755
NCT05100771
Lead Sponsor
Praxis Precision Medicines
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions